Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIN-102 Scintigraphy Study in Diabetic Gastroparesis
NCT04208698Phase 2Terminated
- Sponsor
- CinDome Pharma
- Start
- Feb 2020
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of deudomperidone in diabetic gastroparesis, sponsored by CinDome Pharma. Started Feb 2020; status: terminated.
02
Drugs
deudomperidone
03
Conditions
diabetic gastroparesis
Beyond the preview
Go deeper on NCT04208698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04208698.